Scotia Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-36,391
Closed -$2.76M 875
2021
Q1
$2.76M Buy
36,391
+34
+0.1% +$2.56K 0.02% 321
2020
Q4
$2.48M Buy
36,357
+146
+0.4% +$9.1K 0.02% 301
2020
Q3
$1.93M Buy
36,211
+392
+1% +$23.3K 0.02% 298
2020
Q2
$2.09M Buy
+35,819
New +$1.93M 0.03% 257
2019
Q3
Sell
-30,186
Closed -$1.54M 787
2019
Q2
$1.54M Buy
+30,186
New +$1.41M 0.02% 332

Other funds holding SYNH

Scotia Capital's SYNH Position: Q2 2021 in Review

Scotia Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2021, closing a stake of 36,391 shares — an estimated $2.76M sold.

Scotia Capital first reported a position in SYNH in Q2 2019 and held it in 5 quarters. The position peaked at $2.76M in Q1 2021. 342 funds tracked by Wall St. Rank hold SYNH as of Q2 2021.

  • Scotia Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
  • Scotia Capital sold 36,391 Syneos Health, Inc. Class A Common Stock shares in Q2 2021, an estimated $2.76M.
  • Scotia Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2019 and held it in 5 quarters.
  • Scotia Capital's Syneos Health, Inc. Class A Common Stock position peaked at $2.76M in Q1 2021.
  • 342 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2021.

Based on Scotia Capital's 13F filing for Q2 2021, filed 12 Aug 2021.